phytecs

warning: Creating default object from empty value in /home/hemporg/public_html/news/modules/taxonomy/taxonomy.pages.inc on line 34.

U.S.: Hemp Industries Association Presenting 22nd Annual Conference Sept. 27-29

HempIndustriesAssociation(HIA)

Hemp Industries Association (HIA), a non-profit trade association consisting of hundreds of hemp businesses and farmers, has announced will host its annual conference Sunday, September 27 through Tuesday, September 29, at the Hilton Hotel in downtown Lexington, Kentucky.

The three-day conference will feature keynote speaker James Comer, Kentucky Agriculture Commissioner, and expert speakers David Mitlin, professor at Clarkson University, David Williams, agronomist at University of Kentucky, Mike Fata, CEO of Manitoba Harvest Hemp Foods, Ethan Russo, MD, medical director at Phytecs, John Roulac, CEO of Nutiva, plus many others.

Focusing on the expansion of the hemp industry and market in North America, the conference will also feature hemp exhibits, networking opportunities, and a hemp farm tour.

WHAT: Hemp Industries Association 22nd Annual Conference

WHEN: Sunday, September 27 – Tuesday, September 29, 2015

WHERE: Hilton Hotel, Downtown Lexington
369 West Vine Street
Lexington, KY 40507

Held for the first time in Kentucky, the 22nd annual conference occurs at a bright moment in hemp history, as hemp is cultivated in numerous research projects and farms throughout the state.

Exceeding $620 million in retail sales, according to SPINS data and HIA estimates, hemp products are demonstrating significant market growth; with 21.2 percent year over year growth for the category of hemp foods and body care products alone.

U.S.: Former GW Pharmaceuticals Advisor Discusses Future of Medical Cannabis

DrEthanRusso[Ganjapreneur]

Cannabis business website Ganjapreneur has announced its latest podcast episode, which features prominent medical marijuana researcher Dr. Ethan Russo in a conversation about his research regarding the Endocannabinoid System — a unique system found in all vertebrates, including humans, which promotes homeostasis and a biological balance across bodily functions.

In the interview, Ganjapreneur podcast host Shango Los asks Dr. Russo about Endocannabinoid Deficiency (ECD) and the potential for it to be treated with cannabis. As Russo explains, ECD is just coming into general awareness now as a cause behind several conditions including Migraines, Fibromyalgia, Irritable Bowel Syndrome, Phantom Limb Pain, Infantile colic, Glaucoma, PTSD, Bipolar disease and others.

When used as a form of treatment, "A lot of what THC does is paralleled by the effects of... natural chemicals in the body that everyone has," Dr. Russo explained.

Before going public with his research, Dr. Russo worked for years as senior medical advisor for GW Pharmaceuticals; there, he oversaw three separate clinical trials for Sativex, one of the world's first cannabinoid-based medicines to be approved for public use.

Today, he is medical director at Phytecs, a company specializing in the production of cannabis-based treatments related to the endocannabinoid system. Due to legal complications and concerns over the federal legality of his work, Dr. Russo only began to speak publicly about his research earlier this year.

Syndicate content